Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
next couple of days could be a good time to buy..hard to know the downside but can just spread out the buys..its still the same game..it works or it does not..just the price to play has gotten cheaper..who knows why..some externality making a big deal over..this is definitely a case of rather feel bad that i did than how i would feel if i did not..and the game is over realitively soon..no doubt..
anyone know whats going on at research reception currently in progress
Ignateius..any idea how to calculate the total cost of holding short shares over the past year..how does the cost of borrowing work..and is it applied over the life of the short or one time fee..expect its monthly..must be a relatively high fixed cost just to maintain these short positions for so long.
how many weeks can adxs remain a univeral strong buy on all anaysts covering it before market realizes..yes it is..and buys..even without anymore news..maybe the news thats there over the past few months and is imminent..and keeps looking better and better may finally grab some strong buy days..LM engineers adjuunct booster for many different type immune therapies..and vaccines..its in the 10q ..that along with other avenues of exploration not yet known..all in the 10q..imagine the future..this little bio becomes one of the big players..co operating on adjunct therapy..already in advancing trials with big pharma..
no one has ever accurately predicted any deal adxs has made since i have been watching this stock ..which has been way too long now..
no one has ever seen the stock go up after a conference..ever..usually it goes down ...unlike some here who predict a deal every day..or expect a cure to be announced at a conference..i believe there will be more of the same share price behavior for as long as it lasts..no share price rockets..no train leaving the station etc..etc..
sustained and increasing revenue ...will move the share price..like we saw annouced in the 10q..
no trial updates in a long while...status on head and neck, anal, combo trials, her2.... been silent a long time..
for a company with a .40 price per share..this is great news...apparently our bond holders believe there is a future and believe it with 11 million dollars at risk and a big payment in shares..
No rush to buy..probl see low 8s by Friday..buy towards end of day then sell next morning around 10 am..you da bot..lol
One half of shares traded in first hour then grandpa walked it down on low volume..
Time for daily walk down..
Volume is up third straight day..all those shares rarely available finding homes rather quickly..
blueeyedcatch..you must be reading a different board than I am..i just see traders taking advantage of a vanishing opportunity..costs too much to get this kind of pricing..and to benefit who..traders..irrational behavior..or rationale not explained by market hypothesis..
I believe original amgen deal was preceded by a big drop..warrants were available around mid 4s I believe..i remember I bought some..departure for the tight trading range was for a reason..
thewelllnessway..so right..the idea of shorting is to make money..yet the number of short shares remain constants for many months..adding or substracting around the edges..retail taking a ride..but the end game is not shorting for profit..then covering to ride up..the behavior suggests different objective..as to motive..well wouldn't we need to know who is trading...or who is represented by the trades...the stronger the company gets the more intense..the more costly..people trading for bucks are passengers..this action and duration goes beyond that..and continues ..even those about the activity recognize the futility..but it fosters delay, doubt and great hesitantcy for new investors...yesterday was determination alone from shorts ...day before was dampening day..today is follow-up..but the cost and number of shares available to continue must be decreasing..and the 3-4 million shares between today and yesterday did not foster any big sell-off ..just the opposite..people took advantage of the drop..and bought if they could...slowly but surely the activity is abating..
Plenty of financial resources and no interest in covering..who could that be..
Got to love the share price volume drama today..more news imminent.
seems strange investors who haven't sold over the last few weeks would suddenly offer so many shares for sale in the first hour of trading..thats right bigger volume than an average day...this has got to be getting expensive and the pressure may continue to build..with new financial backing on the open market..shorts will let the price run up this week..and when they feel its demand driven value has been reached..they will begin to cover driving the price up and hoping to short the enthusiam ..may not work this time..thats when game over at least for awhile..and to fbg's point we will see if management does anything to help them out.and the more valuable adxs gets the less likely those holding the loans on the short shares may start to call them in..but who knows..it may not matter.
short strategy..contain..then let it run..then cover pushing it even higer..then short it back again..but sustained news will make that a tought go no doubt. With a less regulated FDA and AMGENs fire power..promising results on this trial will give MINE..soon to be renamed..needed visability in weeks to come.
all about volume at this point..with a stock as manipulated as this one pre market isn't too important as it is an easy place to manage price..this week and the rest of the month will see sustained investor interest..pre market volume is exceptional..
blue, worry not our opinions are drops in the ocean..waves upon the sand etc.
shorts can only hope new investor interest in adxs will go unaffected..but much more to come this month..collecting some of the 1 billion in revenue adxs has booked will help too..no doubt.
" and receive development, regulatory and sales milestone payments of up to $475 million".. and IND by FDA is a regulatory milestone..no doubt..without it there is nothing.
think we will see a nice run this week..expect more news..like the milestone payment..could be a nice one.. conferences starting next week..there are three of them with updates on phase 3 and post anaylsis of GOG trial..will be hard to manage the share price..with the tide rushing in the way it is both sector wide and particularly with adxs.
true..but there are milestone payments of around 500 million dollars plus revenue sharing..
in addition to upfront payments and investment..there are also scheduled milestone payments ...one is for acceptance of IND by FDA .
I'm not sure they made the milestone payments assoc with the amgen 500 million deal public..I don't remember it..but do remember that there was a milestone payment for FDA OK to start cllinical trials...pretty exciting.
according to the agreement, as I remember it, adxs will run the early trials and amgen picks up the bill..anybody know the specifics about the milestone payments associated with the Amgen agreement.
believe there is a milestone payment assoc with this ..maybe we hear about that later..
depending on the shorts position and motivation they could be fine for awhile..but then adxs realities will begin to set in..
I think we will see the usual pattern..shorts will cover running up the s/p beyond what it should be..then they will sell again..driving the price back down to some level..depending on the news..and most importantly share demand..
i thought the EU Medical board had already reviewed many of the test results and based on those reviews invited adxs to apply for approval with some additional criteria..I am pretty sure I read that somewhere..it even included a conversation with one of the Board members who talked about the break thru technology adxs offered...Does anyone else remember that..and adxs safety record is amazing across all trials.
shorts are really just issuing sharess at a managed price/volume...the real danger for that strategy is volume..so they more less back off on high volume days then slowly test the water until volume declines then they get back in with this pathetic exchange of shares..praying no one will notice where the price is..then back up..this has gone on for over two years now...this has lead us to some sort of delaying strategy..hoping for bad news somehow..but alas..no..only good news..as a standalone and in combination with other immune interventions.in a variety of cancers..just the acceptance of it on so many levels and by five big pharma partners...How stupid can people be..we are already collecting revenue on our constructs...its booked..almost a billion dollars..
It happened to me just that way..
found it..thanks so much..encouraging..been buying the last few daysk..think this risk/reward is an outstanding opportunity..and i would rather regret doing it than not doing it...very simple equation for me.
your link does not verify your claim about nwbo..
shorts losing ground as the world around us begin to finally see who we are..and there are 8.5 million shares short..out of only 40 million total..this robot trading bs is not going to get them there in fact it cost about 100,000 short shares last 15 day reporting period..of course that won't have any effect on the share price..LOL
the multi uses of the LM platform is very impressive..and is showing its flexiblility with three partner deals..even as a development investment..esp as a development investment in partnership..our own current combo trials must be showing some real promise ..as adxs is now engineering for others..with big potential payoffs and very little risk..facts speak for themselves.
first time The Street ever endorsed adxs..may even be first time they ever mentioned it..esp. in a positive way..that last deal no doubt caught the eye of some well off private investors...like those funding our new partner..better hide my short brothers..
we engineer our LM platform to target whatever cancer cell expression the partner therapy is going after..thereby increasing the effectiveness of that therapy..been the strategy all along..4 partner trials now with Amgen Merk astra..and now this new one..once the early data starts to comd in..we complete our IND with AMGEN..we gotta be golden.
trade volume getting better along with price..we will see..